Transcription
PHARMACEUTICALSPROCUREMENTLISTPharmaceuticals Fund andSupply AgencyFirst EditionApril 2018Addis Ababa, Ethiopia
onsibilityoftheUSAID GlobalHealthSupplyChainProgram ,PEPFAR,PMIortheUnitedStatesgovernment.
PHARMACEUTICALSPROCUREMENT LISTPharmaceuticals Fund andSupply AgencyFirst EditionApril 2018Addis Ababa, Ethiopia
ACKNOWLEDGEMENTThe Pharmaceuticals Fund and Supply Agency (PFSA) would like to expressgratitude to the United States Agency for International Development(USAID) Global Health Supply Chain Program - Procurement and SupplyManagement (GHSC-PSM) project in Ethiopia for the dedicated andfull support to complete this pharmaceuticals procurement list. PFSAalso appreciates the technical support by the Clinton’s Health AccessInitiative (CHAI), JSI/AIDSFree and UNFPA.Special acknowledgement also goes to members of the taskforce listedunder annex I, as well as experts and institutions that took part in theconsultative workshops listed under annex II, III, IV and V for their valuablecontributions.I
FOREWORDPharmacotherapy has always been an integral part of healthcare system andwill remain so in the future.With the advent of innovative interventions itsrole has become even more critical and requires the continuous availabilityof quality, effective and affordable pharmaceuticals. Pharmaceutical Fundand Supply Agency is the public body entrusted with this role in Ethiopia.Though the Agency has been working hard to ensure the continuousavailability of needed pharmaceuticals at service delivery points, thereis still huge gap between demand and supply in pharmaceuticals. So far,there is no defined and agreed upon list of pharmaceuticals that theAgency procures and avails to public health facilities. As part of itstransformation, the Agency has been working on preparing a defined listof pharmaceuticals that will guide its procurement and supply. After seriesof consultations with stakeholders involving relevant experts in each areafrom health facilities, FMOH, RHBs, EPHI, EHIA, development partnersand the Agency, first edition of the list is now ready for use.We are proud to introduce to you this first edition of the PharmaceuticalsProcurement List which has got buy-in by all stakeholders. Properimplementation of the list is expected to bring about significantimprovement in the availability of pharmaceuticals at service deliverypoints.The list will set a reference against which the Agency's performancecan be measured, and health facilities and other stakeholders know whatcan be availed through PFSA. It will also encourage the private sector'sinvolvement in availing pharmaceuticals which are not included in thislist and also persuades them to healthy competition. The list containsall categories of pharmaceuticals with full and standardized descriptionof each product. Users of the list are expected to consistently use thedescriptions used in the list in all communications and transactions theyundertake for smooth exchange of information along the supply chain.The list will be revised every two years in line with advancements in themedical and pharmaceutical sciences, in consultation with stakeholders.II
PHARMACEUTICALS PROCUREMENT LISTWe would like to call upon all stakeholders to provide the necessarysupport for implementation of the list and continue their support inupdating the list by forwarding comments and suggestions to the Agencythrough its website (www.pfsa.gov.et) or via mail (P. O. Box 21904, AddisAbaba).We also would like to take this opportunity to thank all who directly orindirectly contributed for the development of the list.We would finally liketo express FMOH's and PFSA's commitment for proper implementationof the list to improve the availability of pharmaceuticals in the countryand help our community to benefit from the improvement anticipatedafter implementation.Dr. Loko AbrahamDirector GeneralPharmaceuticals Fund andSupply AgencyDr Amir AmanMinisterFederal Ministry of HealthIII
PHARMACEUTICALS PROCUREMENT LISTTABLE OF CONTENTSPAGEAcknowledgement IForeword IIAbbreviation VIIntroduction 11. List of Medicines 51.1. Regular Medicines 51.2 Anticancer Medicines 182. List of Laboratory Reagents, Chemicals and Supplies222.1. Chemicals and Stains 222.2 Clinical Chemistry Reagents 222.3. Hematology Closed System Reagents242.4 Serological and Immunoassay 252.5. Medical Imaging Supplies and Chemicals262.6 Laboratory Supplies 272.7. Miscellaneous Chemicals 283. List of Regular Medical Supplies304. List of Medical Equipment 394.1. Routine Medical Equipment 394.2. Capital Medical Equipment 505. Health Program Pharmaceuticals 545.1. ARls 545.1.1. ARV Medicines 545.1.2. Opportunistic Infection Medicines555.2. STI Medicines 555.3. Family Planning Contraceptives555.4. MNCH Medicines 565.4.1. Maternal Health Medicines 565.5 TBL Pharmaceuticals 565.5.1 Pediatric Anti-Tuberculosis Medicines 565.5.2. Second line Anti-Tuberculosis Medicines565.6. Anti-Leprosy Medicines 575.7. Tuberculosis diagnostics & Laboratory reagents575.7.1 TB Medical Supplies 575.8. Malaria Pharmaceuticals 575.9.Vaccines 585.9.1.Vaccine accessories 585.10. Nutrition 586. Procurement List Summary 597. ANNEXES (Task Force and Workshop Participants)61
ABBREVIATIONSAPTSAuditable Pharmaceuticals Transactions and ServicesCHAIClinton Health Access InitiativeEPHIEthiopian Public Health InstituteFMOHFederal Ministry of HealthGHSC-PSMGlobal Health Supply Chain Program - Procurement andSupply ManagementIPLSIntegrated Pharmaceuticals Logistics SystemMNCHMaternal, Neonatal and Child HealthRHBRegional Health BureauUNFPAUnited Nations Population FundVI
PHARMACEUTICALS PROCUREMENT LISTINTRODUCTIONThe continuous availability of pharmaceuticals is key for the provision ofquality health services. Pharmaceuticals Fund and Supply Agency (PFSA) isa public institution established to ensure continuous availability of qualitypharmaceuticals at an affordable price to public health facilities through needbased pooled procurement. The Agency has made remarkable achievementsover the past years in terms of procurement, distribution, inventorymanagement and warehousing. The type and volume of pharmaceuticalsthe Agency procures and distributes has exponentially increased over thepast years. The value of annually procured pharmaceuticals has increasedby more than 80% in five years’ time (2003 to 2008 E.C.). The value ofpharmaceuticals distributed by the Agency in 2009 E.C. has increased byabout 140% as compared to that of 2003 E.C. In addition to the productsit procures, the Agency also handles the storage and distribution of hugeamount of program products donated by development partners.With respect to infrastructure, a total of 17 modern warehouses wereconstructed at the center and branches of the Agency during the last fiveyears. This has increased the Agency's warehousing capacity to 305,910 m3from the 16,760 m3 that was available when the Agency started operation.The inventory management across the supply chain has shown significantimprovement through implementation of the Integrated PharmaceuticalsLogistics System (IPLS) and the Health Commodity Management InformationSystem (HCMIS). The Agency, in collaboration with stakeholders anddevelopment partners, has also been involved in capacitating the supply chainworkforce at all levels through in-service training, supportive supervision andmentoring.Tens of Thousands of professionals have taken trainings in varioussupply chain areas. With the objective of making itself more accessible tohealth facilities, the Agency has increased its branches to 19. The Agency hasintegrated the supply management of most of the program pharmaceuticalsand is expanding the directly delivery of such products to service deliverypoints. These efforts have resulted in better availability of both revolving andprogram pharmaceuticals in the country.1
Regardless of the efforts made and achievements gained so far, there is stilla huge gap in ensuring the continuous availability of needed pharmaceuticals,this signposts a lot to be done to continuously avail needed pharmaceuticals atservice delivery points. To this end, the Agency has been involved in BusinessProcess Reengineering (BPR) study which enabled the Agency to identify thekey performance gaps and design interventions to optimize its operations.The Agency has already started implementation of the BPR at head office levelthrough restructuring of some sub-processes. The BPR study has identifiedthe absence of an agreed upon procurement list as one of the causes for theinterrupted supply of pharmaceuticals. Though the Agency was establishedto avail essential pharmaceuticals, it has been trying to procure and avail alltypes of pharmaceuticals as per annual requests made from health facilities.This has put the Agency unfocused and having no reference list against whichits performance can be measured despite the increasing efforts being made.This necessitated the need to define the list of pharmaceuticals the Agencyprocures and supplies to public health facilities on regular basis.Defining the list will enable the Agency to be focused on procuring, storingand distributing pharmaceuticals that are essential for the provision ofhealth services for majority of the population.This will improve the Agency'sperformance and result in better availability of these selected pharmaceuticalsand reduce wastage. Health facilities will be clear on what can be supplied bythe Agency on regular basis and look for options to avail products that arenot supplied by the Agency.To this end, the Agency has been refining the list of pharmaceuticals usedfor the annual quantification and procurement on the basis of the typesof pharmaceuticals sent to the Agency by all public hospitals and selectedhealth centers as part of their annual requirement request. It is believed thatthe annual requests from these health facilities have gone through series ofconsultations within each health facility and got approval of the health facilitiesDrug and Therapeutics Committees (DTC). The list of pharmaceuticals(medicines, medical supplies, medical equipment, and laboratory chemicalsand reagents) included in each category of the draft list were criticallyreviewed by relevant experts in the consultative workshops organized.The draft medical equipment list was reviewed in a consultative workshop byexperts of all clinical categories and other relevant professionals from2
PHARMACEUTICALS PROCUREMENT LISTreferral, general and primary hospitals, health Centers, RHBs, FMOH andEPHI. Medical equipment are categorized into capital and non-capital groupsbased on their complexity. Capital equipment are those that require signingofficial agreement with the Agency to initiate the procurement process. TheAgency has decided that tenders for the procurement of capital equipmentwill be floated twice per year to minimize the burden associated with therepetitive tendering in practice so far. Consultative workshop was alsoorganized to review the draft list of laboratory chemicals and reagentsby laboratory and pharmacy professionals from hospitals, health centers,EPHI, RHBs and the Agency. While reviewing the list of products in eachpharmaceutical category, due emphasis was given for standardization ofdescription of each product, in addition to addition and deletion of productsinto/from the draft list.Based on the reviews made on the draft list, descriptions of each productin the Pharmaceutical Directory Service (PDS) of the Agency is revised andstandardized to be used as a reference standard in all operations of theAgency. Following this, final review workshop was organized to finalize thelist. Experts from referral hospitals, RHBs, the Agency and developmentpartners took part in the review workshop and made final polishing on eachcategory of pharmaceuticals.Finally, the list was coded with the national base code in a consultativeworkshop by involving relevant professionals (pharmacists, laboratorytechnologists and engineers) from selected APTS implementing hospitalsin the country. In the base code, the first four letters indicate the parentcompound of the product, the second two numbers indicate both thestrength/length/volume, dosage form and use category of the product. Thebase code is the same for a single product with one generic name whatever the batch, price or country of origin is different. However, for a singleproduct which has the same generic name, the price code, batch numbercode, expiry date code, country of origin code and receiving date code thatwill be entered automatically with the product varies. The code will be usedfor insuring transparency by facilitating auditing of products transacted fromsuppliers up to users (patients).3
The efforts made by the Agency with continuous support from stakeholdersand partners resulted in realization of this first edition of PharmaceuticalsProcurement List for the Agency that has got buy-in by all stakeholders. TheList will be officially communicated to FMOH, RHBs, and health facilitiesfor their reference. The Agency will exert maximum effort to ensure thecontinuous availability of the pharmaceuticals included in the list and thelist will be updated every two years in line with local and global changes indisease management. The Agency will also strengthen its collaboration withall supply chain players to fully realize the goal the list is developed.4
PHARMACEUTICALS PROCUREMENT LISTBaseCode1. LIST OF MEDICINESSNDescriptionUnit1.1. REGULAR be-20Albe-11Allo-10Alpr-1115Alms-2116Alma-1017 e - 250mg – TabletAcetylsalicylic Acid - 300mg - Tablet (Micro fined)Acetylsalicylic Acid - 81mg - Tablet( Enteric Coated)Acyclovir - 200mg – CapsuleAcyclovir - 3% - Eye OintmentAcyclovir - 400mg – TabletAcyclovir - 40mg/ml - Oral SuspensionAcyclovir - 5% - Topical CreamAcyclovir - 500mg - Powder for injectionAdrenaline (Epinephrine) - 0.1% in 1ml ampoule –InjectionAlbendazole - 100mg/5ml - Oral SuspensionAlbendazole - 400mg – TabletAllopurinol - 100mg – TabletAlprazolam - 0.5mg – Tablet*Aluminium Hydroxide Magnesium Hydroxide Simethicone - (225mg 200mg 50mg)/5ml –SuspensionAluminium Hydroxide Magnesium Trisilicate (120mg 250mg) - Tablet (Chewable)Aminophylline - 250mg/10ml in 10ml Ampoule InjectionAmiodarone - 100mg – Tablet*Amitriptyline - 25mg – TabletAmlodipine - 10mg - TabletAmlodipine - 5mg – TabletAmoxicillin - 125mg - Tablet (Dispersible)Amoxicillin - 125mg/5ml - Oral SuspensionAmoxicillin - 250mg – CapsuleAmoxicillin - 250mg - Tablet (Dispersible)Amoxicillin - 250mg/5ml - Oral 0x1010x10100ml100x1010x10100ml5
BaseDescriptionUnitCode27 Amox-02 Amoxicillin - 500mg – Capsule50X10Amoxicillin Clavulanic Acid - (500mg 100mg) in28 Amcl-3010Vial- Powder for InjectionAmoxicillin Clavulanic Acid - (125mg 100ml29 Amcl-2031.25mg)/5ml - Oral SuspensionAmoxicillin Clavulanic Acid - (500mg 125mg) 30 Amcl-145x3Tablet (Film Coated)Amoxicillin Clavulanic Acid - 250mg 125mg - Tab31 Amcl-1210x2let (Film Coated)32 Ampb-31 Amphotericin B - 50mg in vial - Injection (Liposomal)Each33 Ampi-20 Ampicillin - 125mg/5ml - Oral Suspension100ml34 Ampi-01 Ampicillin - 250mg – Capsule100x1035 Ampi-21 Ampicillin - 250mg/5ml - Oral Suspension100ml36 Ampi-02 Ampicillin - 500mg – Capsule50X1037 Ampi-31 Ampicillin Sodium - 500mg in Vial - Injection50Anti-haemorrhoidal (Betamethasone Valer38 Bepl-55 ate Phenylephrine HCl Lidocaine HCl) 20gm(0.5mg 1mg 25mg) – OintmentAnti-haemorrhoidal (Hydrocortisone Framycetin39 Cfce-60 Cinchocaine Esculoside) - (5mg 10mg 5mg1010mg) - SuppositoryAnti-Rho (D) Immune Globulin - 300mcg in 2ml Vial40 AntD-31Each- Injection41 Aten-11 Atenolol - 50mg – Tablet10x1042 Ator-11 Atorvastatin - 20mg – Tablet10x1043 Ator-12 Atorvastatin - 40mg – Tablet10x344 Atro-41 Atropine Sulfate - 1% - Eye Drop15ml45 Atro-30 Atropine Sulfate - 1mg/ml in 1ml ampoule - Injection10x1046 Azel-51 Azelaic Acid - 20% - Cream30gm47 Azit-20 Azithromycin - 200mg/5ml - Oral Suspension15ml48 Azit-10 Azithromycin - 250mg – Tablet3049 Azit-11 Azithromycin - 500mg – Tablet10x3Beclomethasone Propionate - 100mcg/dose - Aerosol 200 Me50 Becp-41(Oral Inhalation)tered doseSN6
PHARMACEUTICALS PROCUREMENT LIST5152BaseCodeBenz-10Benz-1153Besa-56SN54 Bepe-2055 Trom-3056Beta-1057 Phbe-1058 Betd-5059 Betd-5660 Bisa-6061 Bisa-1062 Zepa-1063 Zepa-1164 crim-1065 Bupi-3266 Buph-3067 Cala-5068 calc-1169 calg-3070 Cand-1171 Capt-1072 Capt-1173 Carb-2074 Carb-1175 Cast-2076Cefe-3177Cefi-11DescriptionUnitBenzhexol (Trihexyphenidyl HCL) - 2mg - TabletBenzhexol (Trihexyphenidyl HCL) - 5mg - TabletBenzoic Acid Salicylic Acid - (6% 3%) - TopicalOintmentBenzoyl Peroxide - 5% - SolutionBenztropine (Mesylate) - 1mg/ml in 2ml ampoule InjectionBetamethasone - 0.5mg – TabletBetamethasone Dexchlorpheniramine Maleate (0.25mg 2mg) - TabletBetamethasone Dipropionate - 0.03% - CreamBetamethasone Dipropionate - 0.05% - OintmentBisacodyl - 5mg - SuppositoryBisacodyl - 5mg – TabletBromazepam - 1.5mg – TabletBromazepam - 3mg – TabletBromocriptine Mesylate - 2.5mg - TabletBupivacaine - 0.75% - 2ml - InjectionBupivacaine Hydrochloride - 0.2% in 10ml Vial Injection (Epidural )*Calamine - 5% - LotionCalcium Carbonate - 350mg – Tablet*Calcium gluconate - 10% in 10ml Ampoule - InjectionCandesartan - 8mg – Tablet*Captopril - 12.5mg – TabletCaptopril - 25mg – TabletCarbamazepine - 100mg/5ml – SyrupCarbamazepine - 200mg – TabletCastor oil – LiquidCefepime - 1gm in Vial - Powder for Injection withSolvent Water for Injection*Cefixime - 400mg – 10100ml10x1060mlEach7x27
SNBaseCodeDescriptionCefotaxime Sodium - 0.5g in Vial - Powder for Injection with Solvent Water for Injection79 Ceft-30 Ceftazidime - 0.5g in Vial - Powder for injection*Ceftazidime - 1g in vial - Powder for Injection with80 Ceft-31DiluentCeftriaxone - 0.5g in Vial - Powder for Injection with81 Cefr-315ml DiluentCeftriaxone - 1g in vial - Powder for Injection with82 Cefr-3210ml DiluentCeftriaxone - 250mg in Vial - Powder for Injection83 Cefr-30with 1% Lidocaine Hydrochloride (Intramuscular)84 Ceph-20 Cephalexin - 125mg/5ml - Oral Suspension85 Ceph-01 Cephalexin - 250mg – Capsule86 Ceph-21 Cephalexin - 250mg/5ml - Oral Suspension87 Ceph-02 Cephalexin - 500mg – Capsule88 Cepz-32 Cephazoline Sodium - 1gm - Injection with Diluent89 Ceti-11 Cetirizine - 10mg - Tablet90 Ceti-20 Cetirizine - 1mg/ml - Oral Solution91 Amph-42 Chloramphenicol - 0.5% - Eye/Ear dropChloramphenicol - 0.5% Dexamethasone 0.1% - Eye92 amde-40Drop93 Amph-46 Chloramphenicol - 1% - Eye OintmentChloramphenicol Sodium Succinate - 1g in vial - Pow94 Amph-35der for injectionChlordiazepoxide Clinidium Bromide - (5mg 95 Chcl-102.5mg) - Tablet96 Phen-20 Chlorpheniramine Maleate - 2mg/5ml - Syrup97 Phen-11 Chlorpheniramine Maleate - 4mg - Tablet98 Cpzn-13 Chlorpromazine Hydrochloride - 100mg - Tablet99 Cpzn-11 Chlorpromazine Hydrochloride - 25mg - TabletChlorpromazine Hydrochloride - 25mg/2ml in 2ml100 Cpzn-30Ampoule - Injection101 Cime-31 Cimetidine - 200mg/ml in 2ml ampoule - 0ml10x10100x1010005010
PHARMACEUTICALS PROCUREMENT eCime-11Cipr-40Cipr-10DescriptionCimetidine - 400mg – TabletCiprofloxacin - 0.3% - Eye/Ear dropCiprofloxacin - 250mg – TabletCiprofloxacin - 2mg/ml - Intravenous Infusion (asCipr-30lactate)Cipr-11 Ciprofloxacin - 500mg – TabletCist-30 Cisatracurium- 2mg/ml in 10 ml Ampoule - InjectionClar-11 Clarithromycin - 500mg – TabletClin-10 Clindamycin - 150mg – TabletMiph-10 Clomiphene Citrate - 50mg – TabletMipr-10 Clomipramine HCL - 25mg – TabletNaze-10 Clonazepam - 0.5mg – TabletNaze-11 Clonazepam - 2mg – TabletClot-55 Clotrimazole - 1% - CreamClot-60 Clotrimazole - 100mg - Tablet (Vaginal)Clot-62 Clotrimazole - 500mg - Tablet (Vaginal)Clox-20 Cloxacillin Sodium - 125mg/5ml - Oral SuspensionClox-01 Cloxacillin Sodium - 250mg – CapsuleClox-21 Cloxacillin Sodium - 250mg/5ml - Oral SuspensionClox-02 Cloxacillin Sodium - 500 mg – CapsuleCloxacillin Sodium - 500mg in Vial - Powder forClox-31injectionCloz-12 Clozapine - 100mg – Tablet*Code- 10 Codeine Phosphate - 30mg – TabletDesm -10 Desmopressin Acetate - 100mcg - TabletDexa-40 Dexamethasone - 0.10% - Eye/Ear dropDexa-50 Dexamethasone - 0.25% - Topical CreamDexa-56 Dexamethasone - 0.25% - Topical OintmentDexa-10 Dexamethasone - 0.5mg – TabletDexa-14 Dexamethasone - 4mg – TabletDexa-30 Dexamethasone - 4mg/ml in 1ml Ampoule - 0x1010x1010ml15gm20gm10x1010059
SNBaseCodeDescriptionDextromethorphan Hydro bromide - 15mg/5ml Syrup132 DW40-34 Dextrose - 40% in 20ml - Intravenous InfusionDextrose in Normal Saline - (5% 0.9%) - Intrave133 DNSa-31nous Infusion with Giving SetDextrose in Water - 5% - Intravenous Infusion with134 DW5P-31Giving Set135 Diaz-30 Diazepam - 5 mg/ml in 2ml ampoule - Injection136 Diaz-11 Diazepam - 5mg – Tablet137 Dics-63 Diclofenac Sodium - 100mg - Suppository138 Dics-60 Diclofenac Sodium - 12.5mg - SuppositoryDiclofenac Sodium - 25mg/ml in 3ml ampoule 139 Dics-30Injection140 Dics-11 Diclofenac Sodium - 50mg – Tablet141 Digo-20 Digoxin - 0.05mg/ml – Elixir142 Digo-10 Digoxin - 0.25mg – Tablet143 Digo-31 Digoxin - 0.25mg/ml in 2ml ampoule - Injection144 Dime-11 Dimenhydrinate - 50mg – TabletDiphenhydramine Hydrochloride - 12.5mg/5ml 145 Diph-20ElixirDopamine Hydrochloride - 40mg/ml in 5ml Ampoule146 Dopa-30- Injection147 Doxy-01 Doxycycline - 100mg – Capsule148 Enal-12 Enalapril Maleate - 10mg - Tablet149 Enal-11 Enalapril Maleate - 5mg – TabletErgometrine Maleate - 0.25 mg/ml in 1ml Ampoule 150 Ergo-30InjectionErgotamine Tartrate Caffeine - (1mg 100mg) 151 Erca-10Tablet152 Eryt-20 Erythromycin - 125 mg/5 ml - Oral Suspension153 Eryt-21 Erythromycin - 200mg/5ml - Oral Suspension154 Eryt-10 Erythromycin Stearate - 250 mg - Tablet155 Eryt-11 Erythromycin Stearate - 500mg – 010x1010x10100ml100ml50X1010x10
PHARMACEUTICALS PROCUREMENT LISTSNBaseCodeDescriptionFerrous Fumarate Folic Acid Cyanocobalamin156 Heam-20 Cupric sulfate Manganese sulfate - (200mg 30mcg 1.5mg 2.5mg 2.5mg) - Syrup157 Fesu-20 Ferrous Sulfate - 125mg/5ml – Syrup158 Fesu-11 Ferrous Sulfate - 325mg – Tablet159 Fesu-25 Ferrous Sulfate - 75mg/0.6ml - Oral DropFerrous Sulfate Folic Acid - (150mg 0.5mg) 160 Fefo-10Tablet (Enteric Coated)161 Conf-02 Fluconazole - 100mg – Capsule*162 Conf-12 Fluconazole - 200mg – Tablet163 Fuci -50 Fluocinolone Acetonide - 0.025% - Cream164 Fluo -01 Fluoxetine - 20mg – CapsuleFluphenazine Decanoate - 25 mg/ml in 2ml Ampoule165 Flud-31- Injection (Depot, oily)166 Foli-13 Folic Acid - 5mg – Tablet167 Frus-30 Frusemide - 10mg/ml in 2ml ampoule - Injection168 Frus-11 Frusemide - 40mg – Tablet169 Fusi-50 Fusidic Acid - 2% - Topical Cream170 Gent-40 Gentamicin - 0.3% - Eye/Ear drop171 Gent-30 Gentamycin - 40mg/ml in 2ml - Injection172 Glib-10 Glibenclamide - 5mg – Tablet173 Glyc-60 Glycerin - 1g - SuppositoryGlyceryl Trinitrate (Nitroglycerine) - 0.4mg - Tablet174 Glyt-11(Sublingual)175 Gris-10 Griseofulvin - 125mg – Tablet176 Gris-20 Griseofulvin - 125mg/5ml - Oral Suspension177 Gris-11 Griseofulvin - 250mg – Tablet178 Guai-20 Guaifenesin - 100mg/5ml – Syrup179 Halo-11 Haloperidol - 1.5mg – Tablet180 Halo-13 Haloperidol - 5mg – Tablet181 Halo-30 Haloperidol - 5mg/ml in 1ml Ampule - InjectionHaloperidol Decanoate - 50mg/ml in 1ml Ampoule 182 Hald-30Injection (Depot, 10x10100ml10x1010x1010x10511
-11Cort-56DescriptionHalothane – InhalationHeparin Sulfate - 5000IU/ml in 5ml - InjectionHydralazine - 20mg/ml in 1ml ampoule - InjectionHydrochlorothiazide - 25mg – TabletHydrocortisone Acetate - 1% - Topical OintmentHydrocortisone Sodium Succinate - 50mg/ml in 2ml188 Cort-30ampoule - InjectionHyoscine (Scopolamine) Butyl bromide - 10mg 189 Hyos-11TabletHyoscine (Scopolamine) Butyl bromide - 20mg/ml in190 Hyos-331ml ampoule - Injection191 Ibup-12 Ibuprofen - 400mg – Tablet192 Icht-56 Ichthammol - 10% - Topical Ointment193 Imip-11 Imipramine - 25mg – Tablet194 Indo-60 Indomethacin - 100mg - Suppository195 Indo-01 Indomethacin - 25mg – CapsuleInsulin Isophane Biphasic (Soluble/Isophane Mixture)196 Inpr-31- (30 70)IU/ml in 10ml Vial - Injection(Suspension)Insulin Isophane Human - 100IU/ml in 10ml Vial 197 Inzn-30Injection(Suspension)Insulin Soluble Human - 100IU/ml in 10ml Vial 198 Isnn-30Injection199 Isof-46 Isoflurane inhalationKetamine HCL - 50 mg/ml in 10ml Ampoule Injection200 Keta-31- Injection201 Keto-50 Ketoconazole - 2% - Cream202 Keto-51 Ketoconazole - 2% - shampoo203 Keto-10 Ketoconazole - 200mg – Tablet204 Kyj4-01 KY Jelly (Hydroxy Ethyl Cellulose) – Gel205 Leca-10 Levodopa Carbidopa - (100mg 25mg) - Tablet206 Leca-11 Levodopa Carbidopa - (250 mg 25 mg) - Tablet207 Lido-32 Lidocaine HCL - 2% in 50ml – InjectionLidocaine HCL Adrenaline - (2% 1:200000IU) in208 Liad-3120ml vial - 2gm10x310x32525
PHARMACEUTICALS PROCUREMENT LISTSNBaseCodeDescriptionLidocaine HCL Dextrose - (5% 7.5 %)in 2ml Injection210 Lith-10 Lithium Carbonate - 300mg – Tablet211 Lora-10 Loratadine - 10mg - Tablet212 Lora-20 Loratadine - 5mg/5ml – Syrup213 Lora-11 Lorazepam - 1mg – Tablet214 Lova-11 Lovastatin - 20mg – Tablet215 Mags-34 Magnesium Sulfate - 50% in 10ml ampoule - InjectionMannitol - 20% in500ml Ampoule - Intravenous216 Mann-31Infusion217 Mebe-10 Mebendazole - 100mg – Tablet218 Mebe-20 Mebendazole - 100mg/5ml - Oral Suspension219 Metf-10 Metformin - 500mg – TabletMethyl Prednisolone - 40mg/ml in 1ml ampoule 220 Pred-31Injection221 Sali-56 Methyl salicylate - 25% - Ointment222 Dopm-10 Methyldopa - 250mg – Tablet223 Pram-20 Metoclopramide - 0.2mg/drop - Oral Drop224 Pram-11 Metoclopramide - 10mg - Tablet225 Pram-21 Metoclopramide - 5mg/5ml – Syrup226 Pram-30 Metoclopramide - 5mg/ml in 2ml ampoule - Injection227 Prol-10 Metoprolol - 25mg – Tablet228 Prol-11 Metoprolol - 50mg – Tablet229 Metr-20 Metronidazole - 125mg/5ml - Oral Suspension230 Metr-01 Metronidazole - 250mg – Capsule231 Metr-30 Metronidazole - 5mg/ml - Intravenous Infusion232 Mico-20 Miconazole - 25mg/ml - Oral Gel233 Mico-50 Miconazole Nitrate - 2% - Cream234 Mico-60 Miconazole Nitrate - 200mg - Tablet (Vaginal)235 Morp-33 Morphine Sulfate - 10mg/ml – Injection236 Morp-23 Morphine Sulfate - 20mg/5ml – Syrup237 Morp-14 Morphine Sulfate - 30mg – Tablet209238Lide-30Muvi-20Multivitamin - 0100ml40mg30gm610125ml10x5120ml13
SN239BaseCodeMuvi-11DescriptionMultivitamin with Minerals - TabletNaloxone HCL - 0.02mg/ml in 2ml ampoule 240 Nalo-30Injection241 Neos-30 Neostigmine - 0.5mg/ml in 1ml Ampoule - Injection242 Neos-31 Neostigmine - 2.5mg/ml in 1ml Ampoule - Injection243 Nife-02 Nifedipine - 10mg - Capsule244 Nife-12 Nifedipine - 20mg – Tablet245 Fura-56 Nitrofurazone -0.2% - soluble dressing- Ointment246 Ethn -11 Norethindrone (Norethisterone) - 5mg - Tablet247 Norf-10 Norfloxacin - 400mg – Tablet248 Nyst-65 Nystatin - 100,000IU – Cream249 Nyst-10 Nystatin - 500,000 IU – Tablet250 Olan-11 Olanzapine - 5mg – TabletOmeprazole - 20 mg - Capsule (Enclosing Enteric251 Omep-02Coated Granules)252 Omep-30 Omeprazole - 4mg/ml in 10ml – InjectionOral Rehydration Salt - 20.7g for 1 Littre Preparation253 Orsp-26- PowderOxytetracycline HCL Hydrocortisone Acetate 254 Oxhp-40(5mg 15mg 10.000 Units)/ml - Eye/Ear dropOxytetracycline Hydrochloride - 0.5% - Eye255 Oxyt-45Ointment256 Oxyt-32 Oxytocin - 10 Units/ml in 1ml Ampoule - InjectionPancuronium Bromide - 2 mg/ml in 2ml Ampoule 257 Panc-31Injection258 Para-20 Paracetamol - 120mg/5ml – Syrup259 para-61 Paracetamol - 125mg - Suppository260 Para-13 Paracetamol - 500mg – Tablet261 Penb-36 Penicillin G, Benzathine - 1.2 MIU - Injection262 Penb-37 Penicillin G, Benzathine - 2.4 MIU - Injection263 Penc-35 Penicillin G, Sodium Crystalline - 1 MIU - Injection264 Pent-30 Pentazocine - 30mg/ml in 1 ampoule - Injection265 Perm-55 Permethrin - 0.05 – Cream266 Peth-30 Pethidine HCL - 50mg/ml in 1ml Ampoule - 0ml10x10100x101001001001030gm10
PHARMACEUTICALS PROCUREMENT ptionPhenobarbitone - 120mg/ml - InjectionPhenobarbitone (Phenobarbital) - 100mg - TabletPhenobarbitone (Phenobarbital) - 30mg - TabletPhenobarbitone (Phenobarbital) Sodium - 30mg/ml 270 Barb-31Injection271 Hyda-11 Phenytoin (Diphenhydantoin) - 100mg - TabletPhenytoin (
supply chain areas. With the objective of making itself more accessible to health facilities, the Agency has increased its branches to 19. The Agency has integrated the supply management of most of the program pharmaceuticals and is expanding the direc
